Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2023-05-01 Director's Dealing
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice- Robert Merriel 2 pages 216.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in relevant interests in securities, specifically the exercise of options and resulting shareholding changes. The content is focused on insider share transactions by a company director. The document length is 4026 characters, which is relatively short but contains detailed transaction data. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2023-05-01 English
Activities Report and Appendix 4C 8 pages 430.8KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement titled 'Activity Report and Cash Flow Report for the Quarter Ended 31 March 2023'. It includes detailed financial data such as cash flow statements, cash position, operating activities, investing and financing activities, and payments to related parties. The presence of an Appendix 4C quarterly cash flow report, which is a regulatory requirement for Australian listed entities, confirms this is a quarterly financial report. The document covers a period shorter than a full fiscal year (quarter ended 31 March 2023) and contains substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-04-27 English
Invion launches Interactive Investor Hub 1 page 154
Regulatory Filings Classification · 95% confidence The document is an ASX announcement about the launch of an interactive investor hub by Invion Limited. It is a brief announcement focused on shareholder engagement and providing access to company updates and presentations. There is no financial data, no detailed report, no voting results, no management changes, or other regulatory filings. The document is short (2487 characters) and serves as a general company update rather than a formal report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-04-10 English
General Meeting Presentation 12 pages 18.9MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation dated April 2023, focusing on Invion Limited's expansion of exclusive rights for their photodynamic therapy technology into new territories (USA, Canada, Hong Kong). It includes scientific data on antiviral and antimicrobial activity, market opportunities, and strategic business information. The content is structured as a presentation with disclaimers, market analysis, scientific results, and business strategy. There is no indication of it being a formal regulatory filing, financial report, or voting results. The length (15,000 characters) and content style align with an Investor Presentation, which typically includes detailed financials, strategy, and market positioning for investors. Therefore, the document is best classified as an Investor Presentation (IP).
2023-04-05 English
Results of General Meeting 2 pages 140.1KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX release dated 6 April 2023, titled 'RESULTS OF GENERAL MEETING'. It provides detailed voting results for resolutions passed at a general meeting, including proxy votes and percentages. The content focuses on the official results of shareholder votes at a general meeting, referencing compliance with the Corporations Act and listing rules. There is no indication of it being a full report, financial statements, or management discussion. The document is relatively short (2291 characters) and is clearly an announcement of voting results rather than the meeting materials or the report itself. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-04-05 English
Notice of General Meeting/Proxy Form 49 pages 4.8MB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of General Meeting of Shareholders for Invion Limited, scheduled for 6 April 2023. It includes details about the virtual meeting, instructions for shareholders to participate, proxy voting information, and an explanatory statement regarding a proposed transaction requiring shareholder approval. The document also references an Independent Expert's Report related to the transaction. The content is typical of a Notice of Meeting and Proxy Statement, which is sent to shareholders to inform them about the meeting agenda and solicit votes. It is not a report of voting results, nor is it a full financial report or earnings release. It is not a proxy solicitation document in the strict sense of a DEF 14A filing but is a Notice of Meeting with explanatory materials. Therefore, the best fitting category is "Declaration of Voting Results & Voting Rights Announcements (DVA)" is not appropriate because this is a notice before the meeting, not results. It is also not an AGM Information (AGM-R) because it is a General Meeting (EGM) notice. The most appropriate classification is "Proxy Solicitation & Information Statement (PSI)" because it includes the Notice of Meeting, Explanatory Statement, and Proxy Form materials to inform shareholders and solicit votes for the meeting resolutions.
2023-03-06 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.